IXICO (LON:IXI) Share Price Passes Below 200 Day Moving Average – Time to Sell?

IXICO plc (LON:IXI)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 8.42 and traded as low as GBX 7.50. IXICO shares last traded at GBX 8.45, with a volume of 14,599 shares changing hands.

IXICO Stock Up 2.4%

The firm’s 50 day moving average is GBX 8.50 and its 200-day moving average is GBX 8.42. The firm has a market cap of £18.50 million, a PE ratio of -4.33, a P/E/G ratio of -0.38 and a beta of 0.13. The company has a quick ratio of 4.90, a current ratio of 2.83 and a debt-to-equity ratio of 5.22.

IXICO (LON:IXI) last released its earnings results on Tuesday, May 19th. The company reported GBX (1.21) EPS for the quarter. The firm had revenue of GBX 395 million during the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. As a group, equities research analysts expect that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

Insider Activity

In other IXICO news, insider Mark Warne acquired 50,006 shares of the stock in a transaction dated Wednesday, July 15th. The stock was acquired at an average price of GBX 8 per share, with a total value of £4,000.48. 3.05% of the stock is owned by company insiders.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.